What evidence is used to formulate the recommendations for the treatment of dyslipidemia?
The target LDL-C and non HDL-C levels are derived from several randomized controlled trials where the LDL-C levels achieved for patients showing benefit are used to suggest targets. Thus, references for the studies from which targets are derived are listed and targets are considered as level of evidence C. Trials involving other secondary prevention therapies also have influenced major practice guidelines used to formulate the recommendations in the present update.